Savient Pharmaceuticals Inc (NASDAQOTH:SVNTQ)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

2
Player Avatar rwpaules (96.16) Submitted: 5/2/2012 2:33:58 PM : Underperform Start Price: $1.55 SVNTQ Score: +60.83

Only a matter of time before this puppy rolls over and dies.

Featured Broker Partners


Advertisement